{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:33:38Z","timestamp":1794368018764,"version":"4.9.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n                  <jats:p>Preimplantation genetic testing comprises a group of genetic assays used to evaluate embryos before transfer to the uterus. Preimplantation genetic testing-monogenic is targeted to single gene disorders, and preimplantation genetic testing-aneuploidy is a broader test that screens for aneuploidy in all chromosomes, including the 22 pairs of autosomes and the sex chromosomes X and Y. To test embryos that are at risk for chromosome gains and losses related to parental structural chromosomal abnormalities (eg, translocations, inversions, deletions, and insertions), preimplantation genetic testing-structural rearrangements is used. Independent of the preimplantation genetic testing modality employed, false-positive and false-negative results are possible. Patients and health care providers should be aware that a \u201cnormal\u201d or negative preimplantation genetic test result is not a guarantee of a newborn without genetic abnormalities. Traditional diagnostic testing or screening for aneuploidy should be offered to all patients who have had preimplantation genetic testing-aneuploidy, in accordance with recommendations for all pregnant patients. It is especially important to offer diagnostic testing or screening for aneuploidy after preimplantation genetic testing-monogenic or preimplantation genetic testing-structural rearrangements if concurrent preimplantation genetic testing-aneuploidy is not performed. Many limitations exist to preimplantation genetic testing and include challenges in detecting microdeletions and microduplications, de novo variants, and imprinting disorders. An emerging problem has been detection of mosaicism during preimplantation genetic testing-aneuploidy. The clinical utility of preimplantation genetic testing-monogenic and preimplantation genetic testing-structural rearrangements is firmly established; however, the best use of preimplantation genetic testing-aneuploidy remains to be determined. Future research is necessary to establish the overall clinical utility for preimplantation genetic testing-aneuploidy, the subset of patients that may benefit from preimplantation genetic testing-aneuploidy, the clinical significance of mosaicism, and residual risk for aneuploidy in preimplantation genetic testing-aneuploidy screened embryos.<\/jats:p>","DOI":"10.1097\/aog.0000000000003714","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T23:53:50Z","timestamp":1582242830000},"page":"e133-e137","source":"Crossref","is-referenced-by-count":64,"title":["Preimplantation Genetic Testing"],"prefix":"10.1097","volume":"135","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.fertnstert.2017.03.023","article-title":"Mosaicism between trophectoderm and inner cell mass","volume":"107","author":"Capalbo","year":"2017","journal-title":"Fertil Steril"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jme.2004.010348","article-title":"Preimplantation HLA typing: having children to save our loved ones","volume":"31","author":"Devolder","year":"2005","journal-title":"J Med Ethics"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/AOG.0b013e31817d252f","article-title":"Ethical issues in genetic testing. ACOG Committee Opinion No. 410. American College of Obstetricians and Gynecologists","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.fertnstert.2018.04.003","article-title":"Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion","volume":"109","year":"2018","journal-title":"Fertil Steril"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/humrep\/dex265","article-title":"ESHRE PGD consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013","volume":"32","author":"De Rycke","year":"2017","journal-title":"Hum Reprod"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0015-0282(16)58399-X","article-title":"Birth of healthy children after preimplantation diagnosis of common aneuploidies by polar body fluorescent in situ hybridization analysis. Preimplantation Genetics Group","volume":"66","author":"Verlinsky","year":"1996","journal-title":"Fertil Steril"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0015-0282(97)00412-3","article-title":"Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos","volume":"68","author":"Gianaroli","year":"1997","journal-title":"Fertil Steril"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10815-016-0740-2","article-title":"Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences?","volume":"33","author":"Brezina","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa067744","article-title":"In vitro fertilization with preimplantation genetic screening","volume":"357","author":"Mastenbroek","year":"2007","journal-title":"N Engl J Med"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1472-6483(10)60414-2","article-title":"Prospectively randomized controlled trial of PGS in IVF\/ICSI patients with poor implantation","volume":"17","author":"Blockeel","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2013.04.039","article-title":"Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial","volume":"100","author":"Scott","year":"2013","journal-title":"Fertil Steril"},{"issue":"suppl 5","key":"R12-20230711","first-page":"S136","article-title":"Preimplantation genetic testing: a practice committee opinion. Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine","volume":"90","year":"2008","journal-title":"Fertil Steril"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/humrep\/dep476","article-title":"What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee","volume":"25","author":"Harper","year":"2010","journal-title":"Hum Reprod"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/humrep\/deu303","article-title":"The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review","volume":"30","author":"Lee","year":"2015","journal-title":"Hum Reprod"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.fertnstert.2017.03.011","article-title":"In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study","volume":"107","author":"Rubio","year":"2017","journal-title":"Fertil Steril"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","article-title":"The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology","volume":"109","year":"2018","journal-title":"Fertil Steril"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.fertnstert.2017.03.019","article-title":"Assessing the true incidence of mosaicism in preimplantation embryos","volume":"107","author":"Vera-Rodriguez","year":"2017","journal-title":"Fertil Steril"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.fertnstert.2018.10.019","article-title":"One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies","volume":"111","author":"Victor","year":"2019","journal-title":"Fertil Steril"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMc1500421","article-title":"Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts","volume":"373","author":"Greco","year":"2015","journal-title":"N Engl J Med"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12958-016-0193-6","article-title":"Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. International PGS Consortium Study Group","volume":"14","author":"Gleicher","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/humrep\/dev159","article-title":"Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study","volume":"30","author":"Ubaldi","year":"2015","journal-title":"Hum Reprod"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/AOG.0000000000001405","article-title":"Prenatal diagnostic testing for genetic disorders. Practice Bulletin No. 162. American College of Obstetricians and Gynecologists","volume":"127","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T17:51:43Z","timestamp":1689097903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003714"}},"subtitle":["ACOG Committee Opinion, Number 799"],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003714","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}